Please join the #lcsm community and moderator Brendon Stiles (@BrendonStilesMD) for our next #LCSM Chat on Thursday, September 19th, 2019, at 8 pm Eastern Time (5 pm Pacific).

Clinicians, researchers, patients and advocates from all over the world attended the 2019 World Conference on Lung Cancer (#WCLC19) from September 7-10 in Barcelona.  This annual event, hosted by the International Association for the Study of Lung Cancer (IASLC), is a showcase for all of the latest news and advances in lung cancer.  The meeting is somewhat unique in that it is multidisciplinary in nature and covers the breadth of the disease, from risk factors and prevention, to screening for lung cancer, to staging and molecular classification, to surgery and radiation therapy for early stage disease, and to immunotherapy, targeted therapy, and novel therapeutics for patients with advanced cancer.

WCLC19 offers a truly breathtaking and diverse collection of invited talks and original scientific presentations.  Better yet, it is a chance to bring everyone interested in lung cancer together in one place to learn from each other and to foster future collaborations.  Increasingly the meeting has also embraced the role that patients and advocates should have at the table during scientific meetings.  This year, the IASLC unveiled their STARS program (Supportive Training for Advocates on Research and Science), training designed to increase the ability of patients and advocates to provide accurate scientific translation to their peer groups and to provide the patient perspective to lung cancer research and policy.

The meeting and the STARS program were both amazing.  Several themes emerged at #WCLC19, which are all reflective of the intense interest in improving lung cancer outcomes throughout the world.  With that in mind, #LCSM Chat this week will cover some of the highlights of #WCLC19 using the following questions:

• T1. Lung cancer screening was a hot topic at #WCLC19. What is new in that area?
• T2. What is important to know about molecular testing? Is universal testing coming?
• T3. What was new at #WCLC19 regarding immunotherapy?
• T4. Are there any exciting new targets being investigated in lung cancer?
• T5. What was STARS and how can patients/advocates get more involved at scientific meetings?

We are excited to have you join us for this #LCSM Chat.  Please join us this Thursday and please remember to include #lcsm in ALL your tweets so the other chat participants can see them. You can read a primer on participating in the chat here.